Jubilant Pharmova Limited Capital Reinvestment Ratio
Jubilant Pharmova Limited capital reinvestment ratio. Jubilant Pharmova Limited (JUBLPHARMA) has a Capital Reinvestment Ratio of 2.00x as of September 2025, meaning it reinvests 2% of its operating cash flow (Rs3.69 Billion) in capital expenditures (Rs7.40 Billion). See Jubilant Pharmova Limited (JUBLPHARMA) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Jubilant Pharmova Limited (2006–2025)
Capital reinvestment ratio of Jubilant Pharmova Limited from 2006 to 2025. This chart tracks Jubilant Pharmova Limited's Capital Reinvestment Ratio across 18 annual periods. See Jubilant Pharmova Limited financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Jubilant Pharmova Limited Capital Reinvestment Ratio by Year (2006–2025)
Jubilant Pharmova Limited capital reinvestment ratio by year from 2006 to 2025. For the full cash flow conversion analysis, see JUBLPHARMA cash flow metrics.
| Year | Reinvestment Ratio | Operating CF (INR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 1.04x | Rs10.72 Billion | Rs11.16 Billion | ▲ +12.6% |
| 2024 | 0.92x | Rs9.71 Billion | Rs8.98 Billion | ▼ -25.0% |
| 2023 | 1.23x | Rs6.61 Billion | Rs8.14 Billion | ▲ +72.1% |
| 2022 | 0.72x | Rs8.38 Billion | Rs6.00 Billion | ▲ +142.3% |
| 2021 | 0.30x | Rs17.84 Billion | Rs5.27 Billion | ▼ -20.6% |
| 2020 | 0.37x | Rs15.43 Billion | Rs5.74 Billion | ▼ -36.4% |
| 2019 | 0.58x | Rs11.22 Billion | Rs6.56 Billion | ▲ +55.8% |
| 2018 | 0.38x | Rs13.03 Billion | Rs4.89 Billion | ▲ +2.6% |
| 2017 | 0.37x | Rs12.68 Billion | Rs4.64 Billion | ▲ +12.3% |
| 2016 | 0.33x | Rs10.92 Billion | Rs3.56 Billion | ▼ -32.0% |
| 2015 | 0.48x | Rs7.83 Billion | Rs3.75 Billion | ▲ +32.1% |
| 2014 | 0.36x | Rs8.03 Billion | Rs2.91 Billion | ▼ -24.3% |
| 2013 | 0.48x | Rs9.70 Billion | Rs4.64 Billion | ▼ -44.9% |
| 2012 | 0.87x | Rs7.08 Billion | Rs6.15 Billion | ▼ -42.0% |
| 2011 | 1.50x | Rs3.88 Billion | Rs5.81 Billion | ▲ +245.8% |
| 2010 | 0.43x | Rs7.10 Billion | Rs3.08 Billion | ▼ -63.8% |
| 2009 | 1.20x | Rs5.58 Billion | Rs6.68 Billion | ▼ -93.8% |
| 2006 | 19.29x | Rs141.82 Million | Rs2.74 Billion | — |